Global Herpes Treatment Market Insights, Forecast to 2025

Publisher Name :
Date: 06-Jun-2019
No. of pages: 118
Inquire Before Buying

Genital herpes is a common sexually transmitted disease. With the increase in population of various regions, there is also an increase in the rate of health issues around the world. As the rate of diseases grow, the treatment markets are also expected to grow substantially. With respect to sexually transmitted disease like genital herpes, its treatment market includes different drug types like Acyclovir, Valacyclovir and Famciclovir. The indication of genital herpes include HSV-1 and HSV-2. 

The rising prevalence of shingles or herpes zoster in the older population is one of the key drivers responsible for the market's growth. According to the center for disease control and prevention (CDC), almost one in every three individuals in the US are likely to develop shingles during their lifetime. People aged 50 years and above can develop this disease due to weakened immune system. Complications associated with this disease such as post-herpetic neuralgia (PHN) can cause severe pain in the areas where the rashes occurred due to shingles. People administered with immunosuppressants in the past can also develop the disease. CDC recommends that one dose of the zoster vaccine must be prescribed to adults who are 60 years and above to reduce the probability of the disease and PHN. This will drive the demand for drugs for virus types such as herpes simplex and herpes zoster, subsequently fueling market growth.

One of the key trends that will stimulate growth in the global herpes treatment market in the coming years is the emergence of novel therapies. GEN-003 vaccine, developed by Genocea is under clinical trials and is effective in controlling both the shedding and outbreak of herpes simplex virus or HSV-2 infection. Shingrix vaccine developed for the treatment of herpes zoster or shingles is also expected to change the market landscape once launched in the forthcoming years.

The global Herpes Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Herpes Treatment market based on company, product type, end user and key regions.

This report studies the global market size of Herpes Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Herpes Treatment in these regions.

This research report categorizes the global Herpes Treatment market by top players/brands, region, type and end user. This report also studies the global Herpes Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Gilead

- GlaxoSmithKline

- Merck

- Novartis

- Abbott

- Mylan

- Teva Pharmaceutical Industries

- Vical

Market size by Product

- Acyclovir

- Valacyclovir

- Famciclovir

Market size by End User

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

- Drug Stores

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Herpes Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Herpes Treatment market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Herpes Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Herpes Treatment submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Herpes Treatment are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Herpes Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Herpes Treatment Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Herpes Treatment Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Herpes Treatment Market Size Growth Rate by Product
1.4.2 Acyclovir
1.4.3 Valacyclovir
1.4.4 Famciclovir
1.5 Market by End User
1.5.1 Global Herpes Treatment Market Size Growth Rate by End User
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.5.5 Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Herpes Treatment Market Size
2.1.1 Global Herpes Treatment Revenue 2014-2025
2.1.2 Global Herpes Treatment Sales 2014-2025
2.2 Herpes Treatment Growth Rate by Regions
2.2.1 Global Herpes Treatment Sales by Regions
2.2.2 Global Herpes Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Herpes Treatment Sales by Manufacturers
3.1.1 Herpes Treatment Sales by Manufacturers
3.1.2 Herpes Treatment Sales Market Share by Manufacturers
3.1.3 Global Herpes Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Herpes Treatment Revenue by Manufacturers
3.2.1 Herpes Treatment Revenue by Manufacturers (2014-2019)
3.2.2 Herpes Treatment Revenue Share by Manufacturers (2014-2019)
3.3 Herpes Treatment Price by Manufacturers
3.4 Herpes Treatment Manufacturing Base Distribution, Product Types
3.4.1 Herpes Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Herpes Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Herpes Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Herpes Treatment Sales by Product
4.2 Global Herpes Treatment Revenue by Product
4.3 Herpes Treatment Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Herpes Treatment Breakdown Data by End User
6 North America
6.1 North America Herpes Treatment by Countries
6.1.1 North America Herpes Treatment Sales by Countries
6.1.2 North America Herpes Treatment Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Herpes Treatment by Product
6.3 North America Herpes Treatment by End User
7 Europe
7.1 Europe Herpes Treatment by Countries
7.1.1 Europe Herpes Treatment Sales by Countries
7.1.2 Europe Herpes Treatment Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Herpes Treatment by Product
7.3 Europe Herpes Treatment by End User
8 Asia Pacific
8.1 Asia Pacific Herpes Treatment by Countries
8.1.1 Asia Pacific Herpes Treatment Sales by Countries
8.1.2 Asia Pacific Herpes Treatment Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Herpes Treatment by Product
8.3 Asia Pacific Herpes Treatment by End User
9 Central & South America
9.1 Central & South America Herpes Treatment by Countries
9.1.1 Central & South America Herpes Treatment Sales by Countries
9.1.2 Central & South America Herpes Treatment Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Herpes Treatment by Product
9.3 Central & South America Herpes Treatment by End User
10 Middle East and Africa
10.1 Middle East and Africa Herpes Treatment by Countries
10.1.1 Middle East and Africa Herpes Treatment Sales by Countries
10.1.2 Middle East and Africa Herpes Treatment Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Herpes Treatment by Product
10.3 Middle East and Africa Herpes Treatment by End User
11 Company Profiles
11.1 Gilead
11.1.1 Gilead Company Details
11.1.2 Company Business Overview
11.1.3 Gilead Herpes Treatment Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Gilead Herpes Treatment Products Offered
11.1.5 Gilead Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 Company Business Overview
11.2.3 GlaxoSmithKline Herpes Treatment Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GlaxoSmithKline Herpes Treatment Products Offered
11.2.5 GlaxoSmithKline Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Business Overview
11.3.3 Merck Herpes Treatment Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck Herpes Treatment Products Offered
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Company Business Overview
11.4.3 Novartis Herpes Treatment Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Novartis Herpes Treatment Products Offered
11.4.5 Novartis Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Company Business Overview
11.5.3 Abbott Herpes Treatment Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Abbott Herpes Treatment Products Offered
11.5.5 Abbott Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Company Business Overview
11.6.3 Mylan Herpes Treatment Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Mylan Herpes Treatment Products Offered
11.6.5 Mylan Recent Development
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Details
11.7.2 Company Business Overview
11.7.3 Teva Pharmaceutical Industries Herpes Treatment Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Teva Pharmaceutical Industries Herpes Treatment Products Offered
11.7.5 Teva Pharmaceutical Industries Recent Development
11.8 Vical
11.8.1 Vical Company Details
11.8.2 Company Business Overview
11.8.3 Vical Herpes Treatment Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Vical Herpes Treatment Products Offered
11.8.5 Vical Recent Development
12 Future Forecast
12.1 Herpes Treatment Market Forecast by Regions
12.1.1 Global Herpes Treatment Sales Forecast by Regions 2019-2025
12.1.2 Global Herpes Treatment Revenue Forecast by Regions 2019-2025
12.2 Herpes Treatment Market Forecast by Product
12.2.1 Global Herpes Treatment Sales Forecast by Product 2019-2025
12.2.2 Global Herpes Treatment Revenue Forecast by Product 2019-2025
12.3 Herpes Treatment Market Forecast by End User
12.4 North America Herpes Treatment Forecast
12.5 Europe Herpes Treatment Forecast
12.6 Asia Pacific Herpes Treatment Forecast
12.7 Central & South America Herpes Treatment Forecast
12.8 Middle East and Africa Herpes Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Herpes Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Herpes Treatment Product Picture
Table Herpes Treatment Market Segments
Table Key Manufacturers Herpes Treatment Covered
Table Global Herpes Treatment Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global Herpes Treatment Sales Market Share by Product 2014-2025
Figure Acyclovir Product Picture
Table Major Manufacturers of Acyclovir
Figure Valacyclovir Product Picture
Table Major Manufacturers of Valacyclovir
Figure Famciclovir Product Picture
Table Major Manufacturers of Famciclovir
Table Global Herpes Treatment Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Online Pharmacies
Figure Drug Stores
Figure Herpes Treatment Report Years Considered
Figure Global Herpes Treatment Market Size 2014-2025 (Million US$)
Figure Global Herpes Treatment Sales 2014-2025 (K MT)
Table Global Herpes Treatment Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Herpes Treatment Sales by Regions 2014-2019 (K MT)
Table Global Herpes Treatment Sales Market Share by Regions 2014-2019
Figure Global Herpes Treatment Sales Market Share by Regions 2014-2019
Figure 2018 Global Herpes Treatment Sales Market Share by Regions
Table Global Herpes Treatment Revenue by Regions 2014-2019 (Million US$)
Table Global Herpes Treatment Revenue Market Share by Regions 2014-2019
Figure Global Herpes Treatment Revenue Market Share by Regions 2014-2019
Figure 2018 Global Herpes Treatment Revenue Market Share by Regions
Table Global Herpes Treatment Sales by Manufacturers (2014-2019) (K MT)
Table Global Herpes Treatment Sales Share by Manufacturers (2014-2019)
Figure Global Herpes Treatment Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Herpes Treatment Revenue by Manufacturers (2014-2019) (Million USD)
Table Herpes Treatment Revenue Share by Manufacturers (2014-2019)
Figure Herpes Treatment Value Share by Manufacturers in 2018
Table Key Manufacturers Herpes Treatment Price (2014-2019) (USD/MT)
Table Herpes Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Herpes Treatment Product Type
Table Date of International Manufacturers Enter into Herpes Treatment Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Herpes Treatment Sales by Product (2014-2019) (K MT)
Table Global Herpes Treatment Sales Share by Product (2014-2019)
Figure Global Herpes Treatment Sales Market Share by Product (2014-2019)
Figure Global Herpes Treatment Sales Market Share by Product in 2018
Table Global Herpes Treatment Revenue by Product (2014-2019) (Million US$)
Table Global Herpes Treatment Revenue Share by Product (2014-2019)
Figure Global Herpes Treatment Revenue Market Share by Product (2014-2019)
Figure Global Herpes Treatment Revenue Market Share by Product in 2018
Table Herpes Treatment Price by Product 2014-2019 (USD/MT)
Table Global Herpes Treatment Sales by End User (2014-2019) (K MT)
Table Global Herpes Treatment Sales Share by End User (2014-2019)
Figure Global Sales Herpes Treatment Market Share by End User (2014-2019)
Figure Global Sales Herpes Treatment Market Share by End User in 2018
Figure North America Herpes Treatment Sales Growth Rate 2014-2019 (K MT)
Figure North America Herpes Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table North America Herpes Treatment Sales by Countries (2014-2019) (K MT)
Table North America Herpes Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 North America Herpes Treatment Sales Market Share by Countries
Table North America Herpes Treatment Revenue by Countries (2014-2019) (Million US$)
Table North America Herpes Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Herpes Treatment Revenue Market Share by Countries
Figure United States Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure United States Herpes Treatment Revenue Growth Rate (2014-2019) (K MT)
Figure Canada Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Canada Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table North America Herpes Treatment Sales by Product (2014-2019) (K MT)
Table North America Herpes Treatment Sales Market Share by Product (2014-2019)
Figure 2018 North America Herpes Treatment Market Share by Product
Table North America Herpes Treatment Sales by End User (2014-2019) (K MT)
Table North America Herpes Treatment Sales Market Share by End User (2014-2019)
Figure 2018 North America Herpes Treatment Market Share by End User
Figure Europe Herpes Treatment Sales Growth Rate 2014-2019 (K MT)
Figure Europe Herpes Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Herpes Treatment Sales by Countries (2014-2019) (K MT)
Table Europe Herpes Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Herpes Treatment Sales Market Share by Countries
Table Europe Herpes Treatment Revenue by Countries (2014-2019) (Million US$)
Table Europe Herpes Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Herpes Treatment Revenue Market Share by Countries
Figure Germany Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Germany Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure France Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure France Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure UK Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Italy Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Russia Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Herpes Treatment Sales by Product (2014-2019) (K MT)
Table Europe Herpes Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Europe Herpes Treatment Market Share by Product
Table Europe Herpes Treatment Sales by End User (2014-2019) (K MT)
Table Europe Herpes Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Europe Herpes Treatment Market Share by End User
Figure Asia Pacific Herpes Treatment Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Herpes Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Herpes Treatment Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Herpes Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Herpes Treatment Sales Market Share by Countries
Table Asia Pacific Herpes Treatment Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Herpes Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Herpes Treatment Revenue Market Share by Countries
Figure China Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure China Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Japan Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Korea Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure India Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure India Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Australia Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Singapore Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Herpes Treatment Sales by Product (2014-2019) (K MT)
Table Asia Pacific Herpes Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Herpes Treatment Market Share by Product
Table Asia Pacific Herpes Treatment Sales by End User (2014-2019) (K MT)
Table Asia Pacific Herpes Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Herpes Treatment Market Share by End User
Figure Central & South America Herpes Treatment Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Herpes Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Herpes Treatment Sales by Countries (2014-2019) (K MT)
Table Central & South America Herpes Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Herpes Treatment Sales Market Share by Countries
Table Central & South America Herpes Treatment Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Herpes Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Herpes Treatment Revenue Market Share by Countries
Figure Brazil Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Argentina Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Herpes Treatment Sales by Product (2014-2019) (K MT)
Table Central & South America Herpes Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Herpes Treatment Market Share by Product
Table Central & South America Herpes Treatment Sales by End User (2014-2019) (K MT)
Table Central & South America Herpes Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Herpes Treatment Market Share by End User
Figure Middle East and Africa Herpes Treatment Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Herpes Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Herpes Treatment Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Herpes Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Herpes Treatment Sales Market Share by Countries
Table Middle East and Africa Herpes Treatment Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Herpes Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Herpes Treatment Revenue Market Share by Countries
Figure GCC Countries Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Turkey Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Herpes Treatment Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Herpes Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Herpes Treatment Sales by Product (2014-2019) (K MT)
Table Middle East and Africa Herpes Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Herpes Treatment Market Share by Product
Table Middle East and Africa Herpes Treatment Sales by End User (2014-2019) (K MT)
Table Middle East and Africa Herpes Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Herpes Treatment Market Share by End User
Table Gilead Company Details
Table Gilead Herpes Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Gilead Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Herpes Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Herpes Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Herpes Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Abbott Company Details
Table Abbott Herpes Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Abbott Recent Development
Table Mylan Company Details
Table Mylan Herpes Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Mylan Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Herpes Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table Vical Company Details
Table Vical Herpes Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Vical Recent Development
Table Global Herpes Treatment Sales Forecast by Regions 2019-2025 (K MT)
Table Global Herpes Treatment Sales Market Share Forecast by Regions 2019-2025
Table Global Herpes Treatment Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Herpes Treatment Revenue Market Share Forecast by Regions 2019-2025
Table Global Herpes Treatment Sales Forecast by Product 2019-2025 (K MT)
Table Global Herpes Treatment Sales Market Share Forecast by Product 2019-2025
Table Global Herpes Treatment Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Herpes Treatment Revenue Market Share Forecast by Product 2019-2025
Table Global Herpes Treatment Sales Forecast by End User 2019-2025 (K MT)
Table Global Herpes Treatment Sales Market Share Forecast by End User 2019-2025
Figure North America Herpes Treatment Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America Herpes Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Herpes Treatment Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe Herpes Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Herpes Treatment Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific Herpes Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Herpes Treatment Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America Herpes Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Herpes Treatment Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa Herpes Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Herpes Treatment Value Chain
Table Herpes Treatment Customers List
Table Herpes Treatment Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Cephalosporin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 109
    Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections. Cephalosporin originally derived from The fungus Acremonium, which was previously known as "Cephalosporium". The global Cephalosporin market was valued at US$ 1380.7 million in 2023 and is anticipated to reach US$ 1346.9 million by 2030, witnessing a CAGR of -0.3% during The forecast period 2024-2030. Market competition is intense. Qilu Antibiotics, Nectar Lifes......
  • Global Polymixin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Polymixin market size was valued at US$ 229.9 million in 2023. With growing demand in downstream market, the Polymixin is forecast to a readjusted size of US$ 291 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Polymixin market. Polymixin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Sepsis Partnering Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The Sepsis Partnering market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sepsis Partnering market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape......
  • Global Cephalosporin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156
    According to our LPI (LP Information) latest study, the global Cephalosporin market size was valued at US$ 1350.7 million in 2023. With growing demand in downstream market, the Cephalosporin is forecast to a readjusted size of US$ 1319.6 million by 2030 with a CAGR of -0.3% during review period. The research report highlights the growth potential of the global Cephalosporin market. Cephalosporin are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Amoxicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Amoxicillin market size was valued at US$ 4512.7 million in 2023. With growing demand in downstream market, the Amoxicillin is forecast to a readjusted size of US$ 5711.7 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Amoxicillin market. Amoxicillin are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Metronidazole Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Metronidazole market size was valued at US$ 110.5 million in 2023. With growing demand in downstream market, the Metronidazole is forecast to a readjusted size of US$ 106.6 million by 2030 with a CAGR of -0.5% during review period. The research report highlights the growth potential of the global Metronidazole market. Metronidazole are expected to show stable growth in the future market. However, product differentiation, redu......
  • Global Drugs for Herpes Labialis (Oral Herpes) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Drugs for Herpes Labialis (Oral Herpes) market size was valued at US$ 2404.5 million in 2023. With growing demand in downstream market, the Drugs for Herpes Labialis (Oral Herpes) is forecast to a readjusted size of US$ 3402.2 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Drugs for Herpes Labialis (Oral Herpes) market. Drugs for Herpes Labialis (Ora......
  • Global Ampicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Ampicillin market size was valued at US$ 161.6 million in 2023. With growing demand in downstream market, the Ampicillin is forecast to a readjusted size of US$ 194.7 million by 2030 with a CAGR of 2.7% during review period. The research report highlights the growth potential of the global Ampicillin market. Ampicillin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......
  • Global Acinetobacter Infections Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Acinetobacter Infections Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Acinetobacter Infections Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Acinetobacter Infections Treatment market. Acinetobacter Infections Treatment are expected to show stable ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs